|
Description
M2 PRESSWIRE-31 August 2007-BUYINS.NET: (WYE) SqueezeTrigger Price is $46.931. There is $665,731,530.00 That Short Sellers Still Need To Cover(C)1994-2007 M2 COMMUNICATIONS LTD
RDATE:31082007
BUYINS.NET / www.squeezetrigger.com is monitoring Wyeth (NYSE:WYE) in real time and just received an alert that is crossing above its primary SqueezeTrigger Price, the price that a short squeeze can start in any stock. There are 14059800 shares that have been shorted at the volume weighted average SqueezeTrigger Price of $46.931. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com .
From January 2005 to July 2007, an aggregate amount of 984077123 shares of WYE have been shorted for a total dollar value of $45,267,547,658.00. The WYE SqueezeTrigger price of $46.931 is the volume weighted average price that all shorts are short in shares of WYE. There is still approximately $665,731,530.00 of potential short covering in shares of WYE.
SqueezeTrigger.com has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger Price for each stock that has been shorted. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of short squeeze events. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com .
Wyeth (NYSE:WYE) Wyeth is engaged in the discovery, development, manufacture, distribution and sale of a diversified line of products in three primary businesses: Wyeth Pharmaceuticals (Pharmaceuticals), Wyeth Consumer Healthcare (Consumer Healthcare) and Fort Dodge Animal Health (Animal Health). Pharmaceuticals include branded human ethical pharmaceuticals, biologicals, vaccines and nutritionals. Principal products include neuroscience therapies, cardiovascular products, nutritionals, gastroenterology drugs, anti-infectives, vaccines, oncology therapies, musculoskeletal therapies, hemophilia treatments, immunological... |
More articles from M2 Presswire
Bulls on Parade BHWF, EGLF, CLXN, and BUGS., August 31, 2007
IVA automation will aid TIX compliance., August 31, 2007
Preferred Managed Services Acquires Bravo Interactive; Launch of Prefe..., August 31, 2007
Lord Malloch-Brown condemns attack in Sudan., August 31, 2007
Kimberly-Clark To Webcast Mark Buthman Presentation And Q&A At Lehman ..., August 31, 2007
Looking for additional articles?
Click here
to search our database of over 3 million articles.
|
%20squeezetrigger%20price%20is%20$46.931.%20there%20is%20$665731530.00%20that%20short%20sellers%20still%20need%20to%20cover.%20%20&position=1)